PUBLISHER: Grand View Research | PRODUCT CODE: 1474853
PUBLISHER: Grand View Research | PRODUCT CODE: 1474853
The China wearable medical devices market size is anticipated to reach USD 6.28 billion by 2030 and is projected to grow at a CAGR of 28.5% from 2024 to 2030, according to a new report by Grand View Research, Inc. Factors such as growing awareness about personal health monitoring, gradual developments in artificial intelligence, and the rising incidence of obesity and chronic illnesses drive the market growth. Instances include continuous glucose monitors (CGM), worn on the body to track blood sugar; electrocardiogram (ECG) patches, which record cardiac information; and wearable blood pressure monitors, which gather patients' variations in blood pressure.
The medical wearables devices market is expanding in China due to the country's aging population and rising healthcare expenditures. Favorable government initiatives and rapidly growing production facilities contribute to the industry's growth. For instance, in December 2021, the China FDA certified Huawei's Watch D as a Class II medical device. As a result, the business can provide the smartwatch with ECG and blood pressure capabilities in China.
Chinese companies have been launching new and innovative wearable medical devices catering to various health needs. For instance, in January 2022, Shenzhen-based manufacturer BBG Group launched a smart insole that can monitor foot pressure and provide real-time feedback to help prevent foot injuries and improve posture.